TABLE 1.
Description of gut microbiota and lung cancer.
| Traits | Consortium | Sample size | Populations | Year | Journal |
|---|---|---|---|---|---|
| Gut | |||||
| Gut microbiota | MiBioGen | 18 340 individuals | European | 2021 | Nature genetics |
| TwinsUK Registry | 1126 individuals | European | 2016 | Cell host and microbe | |
| Lung cancer | |||||
| LC | FinnGen (R9) | 5842 cases | European | 2022 | Nature |
| NSCLC | FinnGen (R9) | 4901 cases | European | 2022 | Nature |
| SCLC | FinnGen (R9) | 676 cases | European | 2022 | Nature |
| NSCLC, adenocarcinoma | FinnGen (R9) | 1553 cases | European | 2022 | Nature |
| NSCLC, squamous carcinoma | FinnGen (R9) | 1413 cases | European | 2022 | Nature |
Abbreviations: LC, lung cancer; NSCLC, non‐small cell lung cancer; SCLC, small cell lung cancer.